<DOC>
	<DOCNO>NCT00607308</DOCNO>
	<brief_summary>The purpose study examine safety , tolerability , pharmacokinetics , pharmacodynamics , immunogenicity single dose PF-04360365 Japanese subject mild moderate Alzheimer 's Disease .</brief_summary>
	<brief_title>A Phase I , Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Japanese male female nonchildbearing potential , ages 5085 Diagnosis probable Alzheimer 's disease , consistent criterion : ( 1 ) National Institute Neurological Communicable Disease Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) 2 ) Text Revision The Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) MiniMental Status Exam score 1626 inclusive RosenModified Hachinski Ischemia score &lt; = 4 Diagnosis history dementia neurodegenerative disorder Diagnosis history clinically significant cerebrovascular disease Specific find magnetic resonance imaging ( MRI ) : cortical infarct , micro hemorrhage , multiple white matter lacunes , extensive white matter abnormality History autoimmune disorder History allergic anaphylactic reaction</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>